Investment Rating - The investment rating for the company is "Outperform the Market" [6][4] Core Views - The company is expected to achieve a net profit attributable to shareholders of 280-420 million yuan in 2025, representing a year-on-year growth of approximately 428%-693%, with a median estimate of 350 million yuan, aligning with previous expectations [1][9] - The non-deductible net profit is projected to be 258-387 million yuan, indicating a year-on-year increase of about 955%-1483%, with a median of 323 million yuan, reflecting a growth of approximately 1244% [1][10] - The rapid growth in 2025 is primarily driven by strong market demand in the recruitment examination training sector and the company's proactive strategies, including regional operations and the "Direct Path to Examination" product [2][10] Financial Forecasts - The company is projected to achieve revenues of 3.371 billion yuan in 2025, with a year-on-year growth of 19% [5] - The net profit forecasts for 2025-2027 are 350 million, 430 million, and 560 million yuan respectively, with corresponding price-to-earnings ratios (PE) of 44, 35, and 27 [4][16] - The company is expected to maintain a high gross margin of 55% and an EBIT margin of 11.5% in 2025 [5][18] Strategic Initiatives - The company is focusing on AI transformation and has established a strategic partnership with Fenbi, which is expected to enhance its AI capabilities and product offerings [2][15] - The "Direct Path to Examination" product is seen as a key reform initiative for 2025, aimed at consolidating the company's leading position in the industry [4][16] - The company has also confirmed the achievement of performance targets related to its employee stock ownership plan for 2025, indicating strong internal alignment with growth objectives [3][14]